Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Drug Monitoring of Meropenem and Clinical Cure Assessment in Critically Ill Pediatric Patients
TCTR20200901002Completed
- Sponsor
- Clinical Pharmacokinetics and Pharmacogenomics Research Unit
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of meropenem in bacterial disease, sponsored by Clinical Pharmacokinetics and Pharmacogenomics Research Unit. Primary endpoints: Meropenem pharmacokinetic parameters and Clinical cure rate. Started Nov 2020; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20200901002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200901002.